Medical device regulations continue to grow more complicated. For … [Read More...] about Regulatory Transformation Demands New Business Cases and KPIs
Main Content
Today on MassDevice
- Exact Sciences launches cancer therapy selection test
- Medtronic: Linq monitor boosts AFib detection 10-fold among stroke patients
- New medtech to watch for in 2023: boosting health outcomes
- Alleviant Medical raises $75M for no-implant heart failure treatment
- DarioHealth, Dexcom partner to integrate CGM into digital health platform
- LivaNova starts limited European launch of perfusion system for cardiopulmonary bypass
- Inspire Medical stock rises on massive Q4 EPS beat
White Papers

Enhancing Supplier Quality Management During Constant Change
| By WTWH Editor
Supply chain disruptions now require medtech manufacturers to use more … [Read More...] about Enhancing Supplier Quality Management During Constant Change
Sponsored Content

When it comes to sales, medical device teams are capable of so much more
| By Sponsored Content
By John Crowder, VP, Healthcare Practice Over the past several years, we’ve seen a tremendous number of providers transition to customer-facing roles in medical devices. As technology advances and more specialized tools become available, clinicians can speak effectively about the use of these solutions in a way that lay people can’t. After all, they’ve been […]
Legal News
3M faces more hurdles over earplug lawsuits strategy
Lawyers representing present and former U.S. military members want a U.S. bankruptcy judge to … [Read More...] about 3M faces more hurdles over earplug lawsuits strategy
Boston Scientific hit with $42M verdict in drug-eluting stents IP case
Boston Scientific (NYSE:BSX) must pay $42 million in unpaid royalties to TissueGen and the … [Read More...] about Boston Scientific hit with $42M verdict in drug-eluting stents IP case
Johnson & Johnson, 3M stocks down on ‘Texas two-step’ decision
Johnson & Johnson (NYSE:JNJ) stock dropped more than 3% in value today after a federal appeals … [Read More...] about Johnson & Johnson, 3M stocks down on ‘Texas two-step’ decision
DePuy Synthes to pay $9.75M to resolve surgeon kickbacks case
Johnson & Johnson's DePuy Synthes has settled with federal prosecutors over allegations that it … [Read More...] about DePuy Synthes to pay $9.75M to resolve surgeon kickbacks case
Report: EU may hit Illumina with maximum penalty over Grail deal
Reuters reported this week that Illumina (Nasdaq:ILMN) may face a heavy penalty in Europe for … [Read More...] about Report: EU may hit Illumina with maximum penalty over Grail deal
Masimo wins round in patent spat with Apple
Masimo (Nasdaq:MASI) announced that a U.S. Administrative Law Judge in Washington, D.C. ruled in its … [Read More...] about Masimo wins round in patent spat with Apple
Sterigenics to pay $408M to settle Illinois ethylene oxide lawsuits
Sterigenics' parent company Sotera Health announced that it has agreed to settle more than 870 … [Read More...] about Sterigenics to pay $408M to settle Illinois ethylene oxide lawsuits
In case you missed it
- Michelle Quinn named acting general counsel for BD
- ITC rules in favor of AliveCor in patent spat with Apple
- BioTelemetry, CardioNet to pay nearly $45M to resolve False Claims Act violation allegations
- J&J’s Auris alleges former employees brought trade secrets to new company Noah Medical
- Apple scores a win in IP spat with AliveCor
Mergers & Acquisitions.

Lantheus acquires Cerveau and its imaging agent for Alzheimer’s
Lantheus (Nasdaq:LNTH) announced that it acquired Cerveau Technologies, a developer of a positron emission tomography imaging agent for detecting Alzheimer’s disease. Cerveau develops the MK-6240 second-generation F 18-labeled PET imaging agent. It targets Tau tangles in Alzheimer’s disease. Bedford, Massachusetts–based Lantheus intends to pay an upfront payment and potential development and commercial milestone payments. It […]

Tandem Diabetes Care completes acquisition of insulin pump maker AMF Medical
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it completed its previously announced acquisition of AMF Medical. San Diego-based Tandem announced plans to acquire the maker of the Sigi patch pump for insulin delivery last month. Switzerland-based AMF Medical does not offer Sigi commercially. The system received FDA breakthrough device designation just over one year ago. The […]

Ra Medical realigns board of directors following merger
Ra Medical Systems (NYSE:RMED) this week announced the realignment of its board of directors in conjunction with the recently announced merger with Catheter Precision. David Jenkins joins the board as executive chair, and James Caruso will serve as a director. Martin Colombatto, Will McGuire and Susann Meline will serve as directors. Additionally, directors Joan Stafslien and […]

Bayer makes radiology play with Blackford Analysis acquisition
Bayer announced today that it acquired AI imaging provider Blackford Analysis as it looks to drive innovation in radiology. The company said in a news release that its strategy includes developing and adopting AI within the clinical workflow. It aims to improve patient care and advance its position in digital medical imaging. Blackford has a […]

Bausch + Lomb buys AcuFocus and its intraocular lens tech
Bausch + Lomb (NYSE:BLCO) announced that its affiliate acquired AcuFocus, a privately held maker of ophthalmic medical devices. The deal remains pursuant to a merger transaction with the parent company of AcuFocus. Neither company disclosed the financial terms of the transaction. AcuFocus develops small aperture intraocular technology. Its portfolio includes the IC-8 Apthera intraocular lens […]

Natus Medical closes acquisition of Micromed
Natus Medical today announced it completed the previously announced acquisition of Micromed Holdings. The deal, announced in December 2022, will add Micromed’s neurophysiology solutions to Natus Medical’s offerings. The financial details of the acquisition were not disclosed. The Micromed acquisition is the first transaction made by the Middleton, Wisconsin-based company since its $1.2 billion acquisition […]

Shockwave Medical to acquire Neovasc for up to $147M
Shockwave Medical (NSDQ:SWAV) today announced it signed an agreement to acquire all of the issued and outstanding common shares of Neovasc (NSDQ:NVCN). Neovasc enrolled its first patient in a clinical trial studying the Neovasc Reducer in January 2022. The company designed the device to reduce angina symptoms in people with refractory angina. It was also reportedly […]